Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 55.73B | 55.88B | 50.22B | 44.79B | 43.07B |
Gross Profit | 14.81B | 12.98B | 11.64B | 9.86B | 10.30B |
EBITDA | 6.76B | 5.66B | 5.07B | 3.62B | 4.42B |
Net Income | 3.96B | 3.29B | 2.54B | 1.89B | 2.31B |
Balance Sheet | |||||
Total Assets | 50.94B | 54.03B | 47.90B | 41.45B | 40.03B |
Cash, Cash Equivalents and Short-Term Investments | 10.21B | 6.32B | 5.40B | 5.55B | 4.52B |
Total Debt | 5.36B | 8.29B | 7.37B | 7.39B | 7.16B |
Total Liabilities | 20.42B | 26.98B | 24.55B | 21.75B | 21.05B |
Stockholders Equity | 25.63B | 22.25B | 19.07B | 17.60B | 16.16B |
Cash Flow | |||||
Free Cash Flow | 7.67B | 680.79M | -697.79M | 2.00B | 4.44B |
Operating Cash Flow | 8.94B | 1.15B | 120.19M | 3.17B | 5.10B |
Investing Cash Flow | -1.02B | -330.72M | -1.73B | -2.07B | -505.09M |
Financing Cash Flow | -3.36B | 76.30M | 15.76M | -100.30M | -3.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥42.15B | 9.55 | 1.08% | 4.95% | 20.09% | ||
78 Outperform | ¥3.18B | 13.37 | 5.19% | 0.09% | -42.75% | ||
77 Outperform | ¥155.13B | 19.38 | 1.23% | 13.27% | -1.75% | ||
76 Outperform | ¥17.92B | 12.07 | 2.34% | 24.48% | 204.62% | ||
74 Outperform | ¥237.60B | 21.82 | 1.82% | 11.91% | 21.70% | ||
73 Outperform | ¥36.56B | 10.21 | 2.37% | 9.40% | -32.82% | ||
71 Outperform | ¥268.21B | 15.07 | 8.32% | 2.78% | 6.19% | 11.34% |